Clinical manifestations of recurrent parotid pleomorphic adenoma
- PMID: 20072694
- PMCID: PMC2804095
- DOI: 10.3342/ceo.2009.2.4.193
Clinical manifestations of recurrent parotid pleomorphic adenoma
Abstract
Objectives: This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA.
Methods: The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity.
Results: Mean age of initial operation in RPA without MT (RPA(-MT)) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA(+MT)) group was significantly greater than that of RPA(-MT) group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA(-MT) group tumor recurrence occurred in 21.4% of patients despite a clear resection margin.
Conclusion: The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.
Keywords: Parotid glancl; Pleomorphic adenoma; Recurrence; Risk factor.
Figures

Similar articles
-
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.J Clin Med. 2022 Mar 25;11(7):1808. doi: 10.3390/jcm11071808. J Clin Med. 2022. PMID: 35407417 Free PMC article.
-
Natural history of recurrent pleomorphic adenoma: implications on management.Head Neck. 2020 Aug;42(8):2058-2066. doi: 10.1002/hed.26137. Epub 2020 Mar 18. Head Neck. 2020. PMID: 32187769
-
[Management of recurrent pleomorphic adenoma of the parotid gland: analysis of the material of Otolaryngology Department, Medical University of Warsaw between 1998 and 2008].Otolaryngol Pol. 2010 Jun;64(7):50-4. doi: 10.1016/S0030-6657(10)70010-X. Otolaryngol Pol. 2010. PMID: 21171312 Polish.
-
Current thinking about the management of recurrent pleomorphic adenoma of the parotid: a structured review.Br J Oral Maxillofac Surg. 2018 May;56(4):243-248. doi: 10.1016/j.bjoms.2018.01.021. Epub 2018 Mar 8. Br J Oral Maxillofac Surg. 2018. PMID: 29526342 Review.
-
The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.Eur Arch Otorhinolaryngol. 2019 Feb;276(2):283-295. doi: 10.1007/s00405-018-5205-z. Epub 2018 Nov 13. Eur Arch Otorhinolaryngol. 2019. PMID: 30426229
Cited by
-
Estrogen, Progesterone and Androgen Receptor in Primary and Recurrent Pleomorphic Salivary Adenomas.Asian Pac J Cancer Prev. 2023 May 1;24(5):1731-1735. doi: 10.31557/APJCP.2023.24.5.1731. Asian Pac J Cancer Prev. 2023. PMID: 37247295 Free PMC article.
-
Massive transcranial parotid pleomorphic adenoma: recurrence after 30 years.J Neurol Surg Rep. 2012 Oct;73(1):1-5. doi: 10.1055/s-0032-1329189. J Neurol Surg Rep. 2012. PMID: 23946917 Free PMC article.
-
"Unraveling the Tapestry": A Retrospective Exploration of Recurrent Parotid Pleomorphic Adenoma Cases.Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3227-3233. doi: 10.1007/s12070-024-04650-7. Epub 2024 Apr 2. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 39130327 Free PMC article.
-
Recurrent pleomorphic adenoma.Head Neck Pathol. 2014;8(3):303-6. doi: 10.1007/s12105-013-0504-6. Epub 2013 Nov 7. Head Neck Pathol. 2014. PMID: 24197723 Free PMC article. No abstract available.
-
Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012.Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3313-9. doi: 10.1007/s00405-016-3921-9. Epub 2016 Feb 12. Eur Arch Otorhinolaryngol. 2016. PMID: 26869475
References
-
- Hanna EY, Lee S, Fan CY, Suen JY. Benign neoplasms of the salivery glands. In: Cummings CW, Flint PW, editors. Cummings Otolaryngology: Head & Neck Surgery. 4th ed. Philadelphia: Mosby; 2005. pp. 1348–1377.
-
- Suh MW, Hah JH, Lee KB, Kwon SK, Jung YH, Sung MW, et al. Immunohistochemical characteristics of primary and recurrent pleomorphic adenoma. Korean J Head Neck Oncol. 2005 Nov;21(2):146–150.
-
- Junquera L, Alonso D, Sampedro A, Fresno F, Albertos JM, Lopez-Arranz JS. Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck. 1999 Oct;21(7):652–656. - PubMed
-
- Bankamp DG, Bierhoff E. Proliferative activity in recurrent and non-recurrent pleomorphic adenoma of the salivary glands. Laryngorhinootologie. 1999 Feb;78(2):77–80. - PubMed
-
- Leverstein H, Tiwari RM, Snow GB, van der Wal JE, van der Waal I. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland: analysis and results in 40 patients. Eur Arch Otorhinolaryngol. 1997;254(7):313–317. - PubMed